Steven Cohen Aclaris Therapeutics, Inc. Transaction History

Point72 Asset Management, L.P.

$36.6 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$6.56 - $10.95 $7.05 Million - $11.8 Million	-1,073,971 Reduced 61.85%	662,529 $4.54 Million
Q2 2023 Aug 14, 2023	BUY	$7.89 - $10.64 $3.09 Million - $4.17 Million	391,900 Added 29.15%	1,736,500 $18 Million
Q1 2023 May 15, 2023	SELL	$7.07 - $17.95 $3.1 Million - $7.86 Million	-438,000 Reduced 24.57%	1,344,600 $10.9 Million
Q4 2022 Feb 14, 2023	SELL	$14.33 - $18.37 $1.01 Million - $1.3 Million	-70,651 Reduced 3.81%	1,782,600 $28.1 Million
Q3 2022 Nov 14, 2022	BUY	$13.07 - $18.22 $1.56 Million - $2.17 Million	119,351 Added 6.88%	1,853,251 $29.2 Million
Q2 2022 Aug 15, 2022	SELL	$10.16 - $17.08 $5.52 Million - $9.28 Million	-543,200 Reduced 23.85%	1,733,900 $24.2 Million
Q1 2022 May 16, 2022	BUY	$9.74 - $17.92 $15.9 Million - $29.3 Million	1,634,200 Added 254.19%	2,277,100 $39.3 Million
Q4 2021 Feb 14, 2022	BUY	$12.27 - $18.49 $3.09 Million - $4.65 Million	251,600 Added 64.3%	642,900 $9.35 Million
Q3 2021 Nov 15, 2021	SELL	$13.38 - $18.8 $1.17 Million - $1.64 Million	-87,300 Reduced 18.24%	391,300 $7.04 Million
Q2 2021 Aug 16, 2021	BUY	$17.08 - $29.6 $2.58 Million - $4.46 Million	150,800 Added 46.0%	478,600 $8.4 Million
Q1 2021 May 17, 2021	BUY	$5.86 - $27.73 $1.92 Million - $9.09 Million	327,800 New	327,800 $8.26 Million
Q3 2018 Nov 14, 2018	SELL	$14.38 - $20.89 $3.88 Million - $5.64 Million	-269,922 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$16.46 - $20.33 $7.58 Million - $9.36 Million	-460,452 Reduced 63.04%	269,922 $5.39 Million
Q1 2018 May 15, 2018	SELL	$17.08 - $25.64 $1.05 Million - $1.58 Million	-61,626 Reduced 7.78%	730,374 $12.8 Million
Q4 2017 Feb 14, 2018	SELL	$21.47 - $27.8 $2.15 Million - $2.79 Million	-100,298 Reduced 11.24%	792,000 $19.5 Million
Q3 2017 Nov 14, 2017	BUY	$23.02 - $28.8 $20.5 Million - $25.7 Million	892,298	892,298 $23 Million

Others Institutions Holding ACRS

# of Institutions

Shares Held

50.7M

Call Options Held

30.6K

Put Options Held

Bml Capital Management, LLC Zionsville, IN

14.3M
Shares

$54.4 Million
9.64% of portfolio
Vanguard Group Inc Valley Forge, PA

4.69M
Shares

$17.9 Million
0.0% of portfolio
D. E. Shaw & Co., Inc. New York, NY

3.37M
Shares

$12.9 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

3.01M
Shares

$11.5 Million
0.0% of portfolio
Rock Springs Capital Management LP Baltimore, MD

2.75M
Shares

$10.5 Million
0.11% of portfolio

View Full List

About Aclaris Therapeutics, Inc.

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $255M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

More about ACRS

Track Steven Cohen's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Account